drugset / Trial / NCT01816529

Topical Safety Study of Topical Diltiazem Hydrochloride

NCT01816529

Phase 1 Unknown 200 enrolled Ventrus Biosciences, Inc
RandomizedSingle-groupTriple-blindTreatment

Summary

The goal of this study will be to determine the potential of Diltiazem Hydrochloride 2% Cream to induce sensitization by repeated topical application to the skin of healthy subjects under controlled conditions.

Timeline

Start
2013-03
Primary completion
2013-06
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Diltiazem Small molecule 2 % Topical
Comparator Sodium Lauryl Sulfate Small molecule 0.1 % Topical

Indications

No indication recorded.